Radiation Oncology Basics Practice Questions

Q: Radiotherapy is least useful in the primary management of which of the following cancers?

Stomach cancer. ### Explanation The effectiveness of radiotherapy (RT) in primary management depends on the **radiosensitivity** of the tumor and the **tolerance** of surrounding normal tissues. **Why Stomach Cancer is the Correct Answer:** Stomach cancer is primarily managed with **surgery** (Total or Subtotal Gastrectomy). Radiotherapy is **least useful as a primary modality** because: 1. **Radio-resistance:** Adenocarcinomas of the stomach are relatively resistant to radiation. 2. **Anatomical Constraints:** The stomach is a mobile organ surrounded by highly radiosensitive structures (liver, kidneys, and small bowel). Delivering a tumoricidal dose (usually >45-50 Gy) would cause significant toxicity to these adjacent organs. RT is typically reserved for adjuvant (post-op) or palliative settings rather than primary curative intent. **Analysis of Incorrect Options:** * **Esophagus Cancer:** RT (often combined with chemotherapy) is a standard primary treatment, especially for squamous cell carcinoma, or as neoadjuvant therapy to downstage tumors before surgery. * **Cervix Cancer:** Radiotherapy (External Beam + Brachytherapy) is the **treatment of choice** for locally advanced cervical cancer (Stage IIB to IVA) and is as effective as surgery in early stages. * **Breast Cancer:** RT is a cornerstone of primary management in **Breast Conserving Therapy (BCT)** to reduce local recurrence and is also used post-mastectomy in high-risk patients. **High-Yield Clinical Pearls for NEET-PG:** * **Most Radiosensitive Tumor:** Seminoma (Testis) and Dysgerminoma (Ovary). * **Most Radioresistant Tumor:** Malignant Melanoma, Osteosarcoma, and Pancreatic Cancer. * **Law of Bergonie and Tribondeau:** Cells are more radiosensitive if they have a high mitotic rate, a long mitotic future, and are undifferentiated. * **Radiotherapy in Stomach:** The most common role is the **MacDonald Regimen** (Adjuvant Chemoradiotherapy).

Q: All of the following isotopes are used in brachytherapy EXCEPT:

Iodine-131 (I131). **Explanation:** The core concept in this question is distinguishing between **Brachytherapy** (sealed source radiotherapy) and **Systemic Radionuclide Therapy** (unsealed source). **Why Iodine-131 is the correct answer:** Iodine-131 is an **unsealed source** primarily used for systemic therapy. It is administered orally or intravenously for the treatment of hyperthyroidism and differentiated thyroid cancer. Because it is distributed throughout the body via the bloodstream to target specific tissues, it is not classified as brachytherapy, which requires the physical placement of a solid, encapsulated source near or inside a tumor. **Analysis of Incorrect Options (Isotopes used in Brachytherapy):** * **Iridium-192 (Ir192):** The most commonly used isotope in modern High Dose Rate (HDR) brachytherapy. It is used in "afterloading" machines for various cancers (e.g., cervix, breast, head, and neck). * **Cesium-137 (Cs137):** Historically the gold standard for Low Dose Rate (LDR) brachytherapy, particularly for cervical cancer (Manchester system). It has a long half-life (~30 years). * **Iodine-125 (I125):** Used as "permanent seeds" for interstitial brachytherapy, most notably in the treatment of low-risk prostate cancer and ocular melanomas. **High-Yield NEET-PG Pearls:** * **Cobalt-60:** Used in Teletherapy (External Beam Radiation), not typically brachytherapy. * **Gold-198 & Palladium-103:** Other common isotopes used for permanent interstitial implants. * **Half-life Check:** Ir-192 (74 days), I-125 (60 days), Cs-137 (30 years), I-131 (8 days). * **Rule of Thumb:** If the isotope is "swallowed or injected" to circulate, it’s systemic; if it’s "placed or implanted" as a solid, it’s brachytherapy.

Q: Which technique is useful for remote afterloading?

Brachytherapy. **Explanation:** **Brachytherapy** is the correct answer because "remote afterloading" is a specific safety technique used in internal radiation therapy. In brachytherapy, radioactive sources are placed directly inside or in close proximity to the tumor. To minimize radiation exposure to healthcare personnel, an applicator is first positioned in the patient; the radioactive source is then mechanically driven from a shielded safe into the applicator via a computerized remote control system (remote afterloading). This eliminates the need for manual handling of "hot" sources. **Why other options are incorrect:** * **Teletherapy (Option A):** This refers to external beam radiation therapy where the radiation source is at a distance from the body (e.g., Cobalt-60 or Linear Accelerator). Since the source is housed within the machine head and never enters the patient, the concept of "afterloading" an applicator does not apply. * **Stereotactic Radiotherapy (Option C):** This is a highly precise form of teletherapy (external beam) that delivers high doses of radiation to a small, well-defined target. It uses specialized positioning and imaging but does not involve internal source loading. **High-Yield Clinical Pearls for NEET-PG:** * **Common Isotopes:** Iridium-192 is the most common isotope used in High Dose Rate (HDR) remote afterloading. * **Types of Brachytherapy:** It can be **Interstitial** (into tissue, e.g., prostate/breast), **Intracavitary** (into a body cavity, e.g., cervix), or **Surface** (on the skin). * **Inverse Square Law:** Brachytherapy relies on this principle, where the radiation dose drops off rapidly as the distance from the source increases, sparing adjacent healthy organs (e.g., rectum/bladder in cervical cancer).

Q: Which of the following is a radiosensitive tumor?

Ewing's sarcoma. ### Explanation **Correct Option: A. Ewing’s Sarcoma** Radiosensitivity refers to the relative susceptibility of cells, tissues, or tumors to the effects of ionizing radiation. In clinical oncology, tumors are categorized based on their response to radiotherapy. **Ewing’s sarcoma** is a highly radiosensitive "small round blue cell tumor." While surgery is often the primary treatment, radiotherapy plays a critical role in local control, especially in unresectable cases or as adjuvant therapy, because these cells undergo rapid apoptosis when exposed to radiation. **Incorrect Options:** * **B. Osteosarcoma:** Unlike Ewing’s, osteosarcoma is considered **radioresistant**. It is a bone-forming tumor that requires very high doses of radiation to achieve cell kill, which often exceeds the tolerance of surrounding normal tissues. Surgery is the mainstay of treatment. * **C. Renal Cell Carcinoma (RCC):** RCC is classically described as **radioresistant**. While stereotactic body radiotherapy (SBRT) is increasingly used for palliation or small lesions, standard fractionated radiotherapy is generally ineffective for primary curative intent. * **D. Pancreatic Carcinoma:** This is a highly aggressive, **radioresistant** adenocarcinoma. The hypoxic microenvironment of pancreatic tumors often contributes to their poor response to ionizing radiation. **High-Yield Clinical Pearls for NEET-PG:** * **Highly Radiosensitive Tumors:** Seminoma (most sensitive), Dysgerminoma, Ewing’s sarcoma, Lymphomas, and Wilms’ tumor. * **Radio-responsive Tumors:** Squamous cell carcinoma (e.g., Cervix, Head & Neck). * **Radioresistant Tumors:** Osteosarcoma, Malignant Melanoma, Renal Cell Carcinoma, and Pancreatic Cancer. * **Bergonie-Tribondeau Law:** Cells are more radiosensitive if they have a high mitotic rate, a long mitotic future, and are undifferentiated.

Q: What is the optimal timing for oxygen administration to be effective during radiotherapy?

Just before starting. **Explanation:** The effectiveness of radiotherapy relies heavily on the **Oxygen Enhancement Ratio (OER)**. Oxygen acts as a potent radiosensitizer by reacting with free radicals produced by ionizing radiation. This reaction "fixes" the damage to the DNA (the **Oxygen Fixation Hypothesis**), making it permanent and lethal to the cancer cell. **1. Why "Just before starting" is correct:** For oxygen to sensitize cells, it must be present at the exact moment of irradiation. Administering oxygen just before starting ensures that the tumor microenvironment is sufficiently oxygenated and that the gas has diffused into the hypoxic core of the tumor before the first beam is delivered. **2. Analysis of incorrect options:** * **During and within microseconds:** While oxygen must be present during the radiation pulse, waiting until the treatment has started to administer it is too late. The chemical reactions (free radical formation) occur in fractions of a second ($10^{-5}$ seconds); if oxygen isn't already present in the tissue, the damage remains repairable. * **After 5 or 10 minutes:** Administering oxygen after the radiation dose is useless. Once the radiation beam stops, the free radicals have already either been repaired by intracellular thiols or have caused non-fixable damage. Oxygen has no "rescue" or delayed sensitizing effect. **Clinical Pearls for NEET-PG:** * **OER Value:** The OER for X-rays and gamma rays is typically **2.5 to 3.0**. * **Hypoxic Cells:** These are **3 times more resistant** to radiation than oxygenated cells. * **Hyperbaric Oxygen:** Historically used to overcome tumor hypoxia, though now largely replaced by hypoxic cell sensitizers (e.g., Nimorazole) or advanced fractionation. * **LET Relationship:** The oxygen effect is maximal with **Low-LET radiation** (X-rays) and minimal/absent with **High-LET radiation** (Alpha particles, Neutrons).

Q: Which of the following tumors is considered radioresistant?

Osteosarcoma. ### Explanation The radiosensitivity of a tumor is primarily determined by its cell of origin, growth fraction, and inherent DNA repair mechanisms. **Why Osteosarcoma is the Correct Answer:** **Osteosarcoma** is a primary bone-forming malignancy characterized by the production of osteoid. It is classically considered **radioresistant**. This resistance is attributed to the tumor's slow doubling time in certain areas, its ability to repair sublethal radiation damage effectively, and the dense, mineralized matrix it produces. Because it does not respond predictably to standard radiotherapy doses, the primary treatment modality remains surgical resection with neoadjuvant and adjuvant chemotherapy. **Analysis of Incorrect Options:** * **A. Ewing’s Sarcoma:** Unlike Osteosarcoma, Ewing’s is a small round blue cell tumor. These tumors typically have a high growth fraction and are highly **radiosensitive**. Radiotherapy is a standard component of management, especially for local control. * **B. Retinoblastoma:** This is a highly **radiosensitive** embryonal tumor. While laser and cryotherapy are used for small lesions, radiotherapy (external beam or brachytherapy) is an effective treatment for larger tumors. * **C. Neuroblastoma:** Another member of the small round blue cell tumor family, it is generally **radiosensitive**. Radiation is frequently used in high-risk cases to treat the primary site or metastatic deposits. **NEET-PG High-Yield Pearls:** * **Most Radiosensitive Tumors:** Seminoma, Dysgerminoma, Lymphoma, and Small round blue cell tumors (Ewing’s, Wilms’, Neuroblastoma). * **Most Radioresistant Tumors:** Osteosarcoma, Chondrosarcoma, Malignant Melanoma, and Renal Cell Carcinoma (RCC). * **Bergonie-Tribondeau Law:** Cells are more radiosensitive if they have a high mitotic rate, a long mitotic future, and are undifferentiated.

Q: Point A and Point B in Manchester localization are used in the radiotherapy treatment of which cancer?

Cervix. **Explanation:** The **Manchester System** is a classic dosimetry system used in **Brachytherapy** for the treatment of **Carcinoma Cervix**. It utilizes specific anatomical reference points to ensure adequate dosage to the tumor while sparing surrounding critical structures. * **Point A:** Located 2 cm superior to the external cervical os and 2 cm lateral to the midline (uterine canal). It represents the location where the uterine artery crosses the ureter. It is the primary point for dose prescription, as it corresponds to the paracervical triangle. * **Point B:** Located 3 cm lateral to Point A (5 cm from the midline). It represents the pelvic side wall and the location of the obturator lymph nodes. It is used to assess the dose to the lateral pelvic structures. **Why other options are incorrect:** * **Kidney:** Radiotherapy for renal tumors (like Wilms tumor) typically involves External Beam Radiation Therapy (EBRT), not intracavitary brachytherapy using the Manchester system. * **Uterus:** While endometrial cancer may use brachytherapy, the Manchester system is specific to the anatomy of the cervix and the paracervical tissues. * **Vagina:** Primary vaginal cancers use different dosimetry systems often based on the depth of the lesion or the surface of the vaginal cylinder, rather than Points A and B. **High-Yield Clinical Pearls for NEET-PG:** * **Point A** is the point of **prescription**; **Point B** is the point of **monitoring** (pelvic wall dose). * The dose at Point B is typically **1/3rd to 1/4th** of the dose at Point A. * Modern radiotherapy is shifting from Point A-based planning to **Image-Guided Brachytherapy (IGBT)** using MRI to define the High-Risk Clinical Target Volume (HR-CTV).

Q: Which of the following tumors is most radioresistant?

Osteosarcoma. **Explanation:** The radiosensitivity of a tumor is primarily determined by its cell of origin, growth fraction, and inherent DNA repair mechanisms. In clinical radiotherapy, tumors are classified on a spectrum from **radiosensitive** (easily destroyed by low doses) to **radioresistant** (requiring extremely high, often toxic, doses for control). **1. Why Osteosarcoma is the Correct Answer:** Osteosarcoma is a bone-forming malignant tumor characterized by the production of osteoid. It is classically considered **radioresistant**. The tumor cells have highly efficient DNA repair mechanisms and often exist in a dense, hypoxic matrix, making them less susceptible to the free radical damage induced by ionizing radiation. Therefore, the primary treatment for Osteosarcoma is surgical resection and chemotherapy, rather than primary radiotherapy. **2. Analysis of Incorrect Options:** * **Lymphoma (Option D):** These are **highly radiosensitive**. Lymphocytes are among the most sensitive cells in the human body (Bergonie-Tribondeau law), and low doses of radiation can induce rapid apoptosis. * **Ewing Sarcoma (Option A):** Unlike Osteosarcoma, Ewing sarcoma is **radiosensitive**. While surgery is often preferred, radiotherapy is a standard component of management for local control. * **Cervical Carcinoma (Option C):** This is **radiosensitive/radiocurable**. Radiotherapy (External Beam + Brachytherapy) is a definitive treatment modality for advanced stages. **Clinical Pearls for NEET-PG:** * **Most Radiosensitive Tumor:** Seminoma (Testis) and Dysgerminoma (Ovary). * **Most Radiosensitive Cell in the Body:** Small Lymphocyte. * **Most Radioresistant Phase of Cell Cycle:** Late S-phase. * **Most Radiosensitive Phase of Cell Cycle:** M-phase (followed by G2). * **Mnemonic for Radioresistant Tumors:** "MOP" — **M**elanoma, **O**steosarcoma, **P**ancreatic Cancer/Renal Cell Carcinoma.

Question 1

Radiotherapy is least useful in the primary management of which of the following cancers?

Accepted Answer

Stomach cancer

Answer

Esophagus cancer

Answer

Cervix cancer

Answer

Breast cancer

Question 2

All of the following isotopes are used in brachytherapy EXCEPT:

Accepted Answer

Iodine-131 (I131)

Answer

Iodine-125 (I125)

Answer

Cesium-137 (Cs137)

Answer

Iridium-192 (Ir192)

Question 3

Which technique is useful for remote afterloading?

Accepted Answer

Brachytherapy

Answer

Teletherapy

Answer

Stereotactic radiotherapy

Answer

None of the above

Question 4

Which of the following is a radiosensitive tumor?

Accepted Answer

Ewing's sarcoma

Answer

Osteosarcoma

Answer

Renal cell carcinoma

Answer

Pancreatic carcinoma

Question 5

Complications of irradiation of the mouth may include all EXCEPT:

Accepted Answer

Accelerated periodontal diseases

Answer

Accelerated caries activity

Answer

Caries in unusual sites

Answer

Xerostomia

Question 6

Intraoperative radiotherapy (RT) is indicated in which of the following malignancies?

Accepted Answer

Carcinoma of the pancreas

Answer

Carcinoma of the cervix

Answer

Carcinoma of the breast

Answer

Carcinoma of the thyroid

Question 7

What is the optimal timing for oxygen administration to be effective during radiotherapy?

Accepted Answer

Just before starting

Answer

During and within microseconds of starting

Answer

After 5 minutes

Answer

After 10 minutes

Question 8

Which of the following tumors is considered radioresistant?

Accepted Answer

Osteosarcoma

Answer

Ewing's sarcoma

Answer

Retinoblastoma

Answer

Neuroblastoma

Question 9

Point A and Point B in Manchester localization are used in the radiotherapy treatment of which cancer?

Accepted Answer

Cervix

Answer

Kidney

Answer

Uterus

Answer

Vagina

Question 10

Which of the following tumors is most radioresistant?

Accepted Answer

Osteosarcoma

Answer

Ewing sarcoma

Answer

Cervical carcinoma

Answer

Lymphoma

Radiation Oncology Basics — MCQs

Radiation Oncology Basics — MCQs

On this page

Practice by Chapter

Want unlimited practice?